Revolutionizing Pharmaceutical Manufacturing: Advances and Challenges of 3D Printing System and Control
Fuente:
arXiv
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Preprint |
| Published: |
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1866929503671943168 |
|---|---|
| author | Kumar, Rahul Singh, Vikram Gupta, Priya |
| author_facet | Kumar, Rahul Singh, Vikram Gupta, Priya |
| contents | The advent of 3D printing has transformed the pharmaceutical industry, enabling precision drug manufacturing with controlled release profiles, dosing, and structural complexity. Additive manufacturing (AM) addresses the growing demand for personalized medicine, overcoming limitations of traditional methods. This technology facilitates tailored dosage forms, complex geometries, and real-time quality control. Recent advancements in drop-on-demand printing, UV curable inks, material science, and regulatory frameworks are discussed. Despite opportunities for cost reduction, flexibility, and decentralized manufacturing, challenges persist in scalability, reproducibility, and regulatory adaptation. This review provides an in-depth analysis of the current state of AM in pharmaceutical manufacturing, exploring recent developments, challenges, and future directions for mainstream integration. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2409_11712 |
| institution | arXiv |
| publishDate | 2024 |
| record_format | arxiv |
| spellingShingle | Revolutionizing Pharmaceutical Manufacturing: Advances and Challenges of 3D Printing System and Control Kumar, Rahul Singh, Vikram Gupta, Priya Systems and Control The advent of 3D printing has transformed the pharmaceutical industry, enabling precision drug manufacturing with controlled release profiles, dosing, and structural complexity. Additive manufacturing (AM) addresses the growing demand for personalized medicine, overcoming limitations of traditional methods. This technology facilitates tailored dosage forms, complex geometries, and real-time quality control. Recent advancements in drop-on-demand printing, UV curable inks, material science, and regulatory frameworks are discussed. Despite opportunities for cost reduction, flexibility, and decentralized manufacturing, challenges persist in scalability, reproducibility, and regulatory adaptation. This review provides an in-depth analysis of the current state of AM in pharmaceutical manufacturing, exploring recent developments, challenges, and future directions for mainstream integration. |
| title | Revolutionizing Pharmaceutical Manufacturing: Advances and Challenges of 3D Printing System and Control |
| topic | Systems and Control |
| url | https://arxiv.org/abs/2409.11712 |